scholarly article | Q13442814 |
P50 | author | Rolf Bjerkvig | Q55223218 |
P2093 | author name string | Fredman P | |
Thorsen F | |||
Tysnes BB | |||
Visted T | |||
Hedberg KM | |||
Mahesparan R | |||
Read TA | |||
P2860 | cites work | Glycolipid markers of astrocytomas and oligodendrogliomas. | Q55476324 |
Expression of mouse sialic acid on gangliosides of a human glioma grown as a xenograft in SCID mice. | Q55476853 | ||
Vascular and perivascular GD3 expression in human glioma. | Q55479497 | ||
Characterization of new gangliosides of the lactotetraose series in murine xenografts of a human glioma cell line. | Q55487688 | ||
Gangliosides of human cerebral astrocytomas. | Q55491085 | ||
Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma | Q37678574 | ||
Glycosphingolipids in cellular interaction, differentiation, and oncogenesis | Q40313054 | ||
Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro | Q40796601 | ||
Growth of precultured human glioma specimens in nude rat brain | Q40940950 | ||
Generation of human monoclonal antibodies against ganglioside antigens and their applications in the diagnosis and therapy of cancer | Q41014965 | ||
In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line | Q41194412 | ||
Occurrence of lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 in human gliomas in vitro and in vivo | Q41658500 | ||
Gangliosides in the human glioma cell line U-118 MG grown in culture or as xenografts in nude rats | Q41725225 | ||
GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody | Q41955835 | ||
Multicellular tumor spheroids from human gliomas maintained in organ culture | Q43508999 | ||
GD3 expression by cultured human tumor cells of neuroectodermal origin | Q45008557 | ||
Sialyllactotetraosylceramide, a ganglioside marker for human malignant gliomas | Q48104945 | ||
Glycosphingolipid component profiles of human gliomas correlate with histological tumour types: analysis of inter-individual and tumour-regional distribution | Q48214307 | ||
Demonstration of ganglioside GD3 in human reactive astrocytes | Q48237876 | ||
Occurrence of ganglioside GD3 in neoplastic astrocytes. An immunocytochemical study in humans | Q48246842 | ||
Expression of gangliosides GD3 and 3'-isoLM1 in autopsy brains from patients with malignant tumors | Q48365819 | ||
Association of Src family tyrosine kinase Lyn with ganglioside GD3 in rat brain. Possible regulation of Lyn by glycosphingolipid in caveolae-like domains. | Q48579497 | ||
Gangliosides in human fetal brain | Q48726946 | ||
CHROMATOGRAPHlC SEPARATION OF HUMAN BRAIN GANGLIOSIDES* | Q51283844 | ||
The presence of foetal ganglioside antigens 3'-isoLM1 and 3'6'-isoLD1 in both glioma tissue and surrounding areas from human brain. | Q52197488 | ||
Human brain gangliosides: developmental changes from early fetal stage to advanced age. | Q52244920 | ||
New insights in glycosphingolipid function: "glycosignaling domain," a cell surface assembly of glycosphingolipids with signal transducer molecules,involved in cell adhesion coupled with signaling. | Q53428521 | ||
P433 | issue | 6 | |
P921 | main subject | glioblastoma | Q282142 |
xenograft | Q64148587 | ||
P304 | page(s) | 451-464 | |
P577 | publication date | 2001-12-01 | |
P1433 | published in | Neuropathology and Applied Neurobiology | Q7002494 |
P1476 | title | The glioma-associated gangliosides 3'-isoLM1, GD3 and GM2 show selective area expression in human glioblastoma xenografts in nude rat brains | |
P478 | volume | 27 |
Q37364358 | Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas |
Q40016148 | Glycosphingolipid antigens in neural tumor cell lines and anti-glycosphingolipid antibodies in sera of patients with neural tumors |
Q48276171 | Human gliosarcoma-associated ganglioside composition is complex and distinctive as evidenced by high-performance mass spectrometric determination and structural characterization |
Q35873775 | Monoclonal antibodies for brain tumour treatment |
Q35192627 | Neurological analyses: focus on gangliosides and mass spectrometry |
Q40628744 | The glial precursor proteoglycan, NG2, is expressed on tumour neovasculature by vascular pericytes in human malignant brain tumours. |